DDInter225 DDInter1180
In 2002, botulinum toxin A, also known as onabotulinumtoxinA or Botox, was the first type A botulism toxin to be introduced into the market for cosmetic use. With a wide variety of applications and favourable safety profile, Botulinum toxin A injection is a minimally invasive and promising treatment for cosmetic imperfections, muscle spasms, and other conditions.[A231819,L32569] A popular use for Botox is the treatment of facial wrinkles and lines, however, there are many uses for the botulinum toxin A in the treatment of dystonia, incontinence, migraine, blepharospasm, and hyperhidrosis.[L32494,L32559]
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Botulinum toxin type A {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Carbinoxamine
Botulinum toxin type A {u} may lead to a major life threatening interaction when taken with {v} Kanamycin
Botulinum toxin type A may cause a moderate interaction that could exacerbate diseases when taken with Carbinoxamine
Botulinum toxin type A may lead to a major life threatening interaction when taken with Kanamycin